SCHEMBL31064876

SCHEMBL31064876

N#Cc1cc(F)c(CN[C@@H]2CCCc3cccnc32)c(F)c1

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 2/20 0.54
HDAC6 Q9UBN7 2/20 0.54
CXCR4 P61073 5/20 0.43
P2RX7 Q99572 6/20 0.38
LRRK2 Q5S007 1/20 0.35
ALDH1A1 P00352 1/20 0.34
LMNA P02545 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
SCN1A P35498 1/20 0.34
SCN5A Q14524 1/20 0.34
SCN8A Q9UQD0 1/20 0.34
JAK2 O60674 1/20 0.34
JAK1 P23458 1/20 0.34
TYK2 P29597 1/20 0.34
JAK3 P52333 1/20 0.34
BACE1 P56817 3/20 0.34
BACE2 Q9Y5Z0 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31064357 0.85 HDAC1 (0.58) HDAC1HDAC6CXCR4P2RX7SCN1A
SCHEMBL4070374 0.82 HDAC1 (0.64) HDAC1HDAC6CXCR4ALDH1A1LMNA
SCHEMBL3373416 0.81 HDAC1 (0.55) HDAC1HDAC6CXCR4ALDH1A1JAK1
SCHEMBL2082282 0.78 HDAC1 (0.54) HDAC1HDAC6CXCR4P2RX7ALDH1A1
SCHEMBL13909820 0.76 HDAC1 (0.76) HDAC1HDAC6CXCR4P2RX7ALDH1A1
SCHEMBL30379489 0.76 HDAC1 (0.61) HDAC1HDAC6CXCR4P2RX7SCN1A
SCHEMBL31380403 0.75 HDAC1 (0.71) HDAC1HDAC6CXCR4P2RX7ALDH1A1
SCHEMBL4887341 0.74 HDAC1 (0.69) HDAC1HDAC6CXCR4ALDH1A1
SCHEMBL4562865 0.74 HDAC1 (0.69) HDAC1HDAC6CXCR4ALDH1A1
SCHEMBL30983297 0.73 HDAC1 (0.45) HDAC1HDAC6CXCR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4688785-A1 5-AMINO-6, 8-DIHYDRO-1H-FURO [3, 4-D] PYRROLO [3, 2-B] PYRIDINE-2-CARBOXAMIDE DERIVATIVES AS MTA-COOPERATIVE INHIBITORS OF PRMT5 Beone Medicines I GmbH (CH) 2026-02-11 EP disclosed
US-20240368177-A1 5-AMINO-6,8-DIHYDRO-1H-FURO[3,4-d]PYRROLO[3,2-b]PYRIDINE-2-CARBOXAMIDE DERIVATIVES AS MTA-COOPERATIVE INHIBITORS OF PRMT5 BEIGENE SWITZERLAND GMBH (CH) 2024-11-07 US disclosed
WO-2024199255-A1 5-AMINO-6, 8-DIHYDRO-1H-FURO [3, 4-d] PYRROLO [3, 2-b] PYRIDINE-2-CARBOXAMIDE DERIVATIVES AS MTA-COOPERATIVE INHIBITORS OF PRMT5 BEIGENE SWITZERLAND GMBH (CH) 2024-10-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240368177-A1 5-AMINO-6,8-DIHYDRO-1H-FURO[3,4-d]PYRROLO[3,2-b]PYRIDINE-2-CARBOXAMIDE DERIVATIVES AS MTA-COOPERATIVE INHIBITORS OF PRMT5 PRMT5, PRMT6, PRMT1 HDAC1 99/4885HDAC6 495/4885CXCR4 4173/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.